NICE· @NICEComms · X·· 5 天前精选AI 评分58
AI 导读
NICE 推荐了一款新的延长生存期治疗药物,用于晚期肛癌,即日起可在 NHS 使用,约250名患者可能受益。这是 NICE 针对该特定类型肛癌推荐的首款药物。
推荐理由
NICE 推荐首个针对该特定类型肛癌的药物,读者可了解这一患者群体的新治疗选择及覆盖人数。
正文
Around 250 people with advanced anal cancer could benefit from a new life-extending treatment recommended by NICE and available on the NHS from today.
It’s the first NICE-recommended drug for this specific form of anal cancer.
Read more: https://orlo.uk/0OsZd
来源:NICE · x.com